This company has been acquired
Silk Road Medical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chas McKhann
Chief executive officer
US$13.4m
Total compensation
CEO salary percentage | 0.8% |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 3.4yrs |
Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Silk Road Medical, Inc (NASDAQ:SILK) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
May 02Silk Road Medical, Inc's (NASDAQ:SILK) Shares Leap 35% Yet They're Still Not Telling The Full Story
Feb 03A Piece Of The Puzzle Missing From Silk Road Medical, Inc's (NASDAQ:SILK) 26% Share Price Climb
Dec 20Is Silk Road Medical (NASDAQ:SILK) Weighed On By Its Debt Load?
Nov 03Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Aug 05Shareholders Should Be Pleased With Silk Road Medical, Inc's (NASDAQ:SILK) Price
May 05Is Silk Road Medical (NASDAQ:SILK) A Risky Investment?
Apr 04Silk Road Medical announces $100M common stock offering
Oct 17Is Silk Road Medical (NASDAQ:SILK) Using Too Much Debt?
Sep 24Silk Road Medical GAAP EPS of -$0.44 beats by $0.02, revenue of $33.17M beats by $2.14M
Jul 26Silk Road Medical: Divergence From Alternative Risk Premia Means Lack Of Upside Capture
Jul 19CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$57m |
Mar 31 2024 | n/a | n/a | -US$53m |
Dec 31 2023 | US$13m | US$106k | -US$56m |
Compensation vs Market: Chas's total compensation ($USD13.42M) is above average for companies of similar size in the US market ($USD3.31M).
Compensation vs Earnings: Insufficient data to compare Chas's compensation with company performance.
CEO
Chas McKhann (55 yo)
less than a year
Tenure
US$13,423,834
Compensation
Mr. Charles S. McKhann, also known as Chas, serves as Chief Executive Officer at Silk Road Medical, Inc since November 02, 2023 and serves as Director since 2023. He serves as President, Chief Executive Of...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | less than a year | US$13.42m | no data | |
CFO & COO | 8.2yrs | US$6.62m | 0.39% $ 4.3m | |
Executive VP | 2.1yrs | US$3.64m | 0.022% $ 243.4k | |
Independent Consultant | less than a year | US$8.28m | 0.63% $ 7.1m | |
Chief Commercial Officer | 4.2yrs | US$4.87m | 0.17% $ 1.9m | |
Executive Vice President of Clinical | 10.2yrs | US$1.97m | 0.29% $ 3.3m | |
Chief Accounting Officer & VP of Finance | 6.6yrs | no data | 0.19% $ 2.1m | |
Compliance Officer & VP of Medical Affairs | 2.7yrs | no data | no data | |
Vice President of Marketing | less than a year | no data | no data | |
Vice President of Human Resources | no data | no data | no data | |
Executive Medical Director | 5.5yrs | no data | no data | |
Investors Relations Officer | no data | no data | no data |
3.4yrs
Average Tenure
55yo
Average Age
Experienced Management: SILK's management team is considered experienced (3.4 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 1.7yrs | US$13.42m | no data | |
Independent Chairman | 17.4yrs | US$263.49k | 0.027% $ 299.1k | |
Independent Director | 11.4yrs | US$212.49k | 0.37% $ 4.1m | |
Independent Director | 6.5yrs | US$228.14k | 0.017% $ 185.6k | |
Independent Director | 3.9yrs | US$221.31k | 0.015% $ 167.9k | |
Independent Director | 17.5yrs | US$202.47k | 0.20% $ 2.2m | |
Independent Director | 3.2yrs | US$207.47k | 0.014% $ 152.3k | |
Independent Director | 3.8yrs | US$220.47k | 0.044% $ 489.6k |
5.2yrs
Average Tenure
59.5yo
Average Age
Experienced Board: SILK's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/09/16 03:04 |
End of Day Share Price | 2024/09/16 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Silk Road Medical, Inc is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | Argus Research Company |
Joanne Wuensch | BMO Capital Markets Equity Research |
Travis Steed | BofA Global Research |